Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study A. Fasano,C. Henchcliffe,H. Sarva,A. Lozano,S. Kalia, K.K.H. Yu,C. Brennan, W. Stemple, N. Abid, M. Yountz, A. Enayetallah, A. Lampron,V. TabarParkinsonism & Related Disorders（2024）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
